Drawing for CLINIGENCE HEALTH

USPTO serial 88510340

CLINIGENCE HEALTH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ROSSMAN, WILLIAM M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CLINIGENCE HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Manuel Valcarcel, Esq.

Manuel Valcarcel, Esq. Greenberg Traurig, P.A.333 S.E. 2nd Avenue, 44th FloorMiami, FL 33131UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Compiling and providing reports, namely, preparing business reports, featuring business and business operational data analytics, metrics and benchmarking for medical professionalsACTIVE—
042Computer and software services, namely, providing temporary use of non-downloadable business intelligence software to store, manage, track, mine and analyze clinical and other patient data and provide reports to support compliance, benchmarking, business intelligence and quality improvement; design, development, updating and maintenance of computer software and database systems; software technical support services for health care providers and administrators, namely, troubleshooting of computer software problems; Software as a service (SAAS) services featuring software for managing, gathering, organizing and sharing data, information and images in the fields of health care and medical research; data analytics and reporting services in the field of medical researchACTIVE—
044Providing data analytics, reports and consulting services in the field of health care, namely, preparation of medical reports providing medical information to doctors and other healthcare providers and payers of healthcareACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 8, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 8, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 5, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 3, 2020EX1GSOU EXTENSION 1 GRANTED—
Aug 3, 2020EXT1SOU EXTENSION 1 FILED—
Aug 3, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 4, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 10, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 10, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 20, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 5, 2019ALIEASSIGNED TO LIE—
Oct 29, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 18, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 17, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 17, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 28, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2019DOCKASSIGNED TO EXAMINER—
Jul 18, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 15, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance